Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Biocryst Pharmaceuticals (BCRX)

Add to Watchlists
Create an Alert
8.555 -0.65  -7.01% NASDAQ Apr 23, 4:59PM BATS Real time Currency in USD
View Full Chart
BCRX Price Chart
View All Events

BCRX Events

Date Type Description
May 08 Misc Q1 2014 Biocryst Pharmaceuticals Earnings Call
Mar 03 Earnings Q1 2014 Biocryst Pharmaceuticals Earnings Results. Estimate: -0.11.
Feb 26 Misc Q4 2013 Biocryst Pharmaceuticals Earnings Call
Feb 26 Earnings Q4 2013 Biocryst Pharmaceuticals Earnings Results. Estimate: -0.11.
Nov 05 Misc Biocryst Third Quarter 2013 Conference Call
Nov 05 Earnings Biocryst Pharmaceuticals 3Q13 Reporting. Estimate: -0.13.
Aug 08 Misc Biocryst Second Quarter 2013 Conference Call
Aug 08 Earnings 2Q13 Reporting: Tuesday, August 6, 2013. Estimate: -0.13.
May 31 Misc AGM Event for Biocryst Pharmaceuticals Inc.
May 07 Misc Biocryst First Quarter 2013 Conference Call
View All Performance Charts

BCRX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Biocryst Pharmaceuticals is up 383.3% over the last year vs S&P 500 Total Return up 22.59%, Lannett up 239.0%, and Endocyte up 36.79%.

Get Quote for

PDF Report for BCRX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download BCRX Pro Report PDF
Advertisement

Portfolio Strategies Featuring BCRX

Did Biocryst Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

BCRX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: North Carolina
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Biocryst Pharmaceuticals Inc. is engaged in the design, optimization and development of novel drugs that block key enzymes involved in the pathogenesis of diseases. Its drug candidates include Peramivir, BCX4161, Forodesine and Ulodesine, among others.

Recent Quotes

Symbol Price Chg Chg % Market Cap
BCRX 8.555 -0.65 -7.01% 508.03M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.